Translational science: What is it and why is it so important?

Drug Discovery Today

Volumn 8, Issue 18, 2003, Pages 813-815

  Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biotechnology; Development; Discovery science; Disease cures; Drug Discovery; Pharmacology; Targeting; Techniques Methods; Translational science

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN; RECOMBINANT PROTEIN; VIRUS VECTOR;

BRAIN DISEASE; CANCER; CHRONIC DISEASE; CONTROLLED DRUG RELEASE; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG INDUSTRY; DRUG TARGETING; DRUG TRANSPORT; EDITORIAL; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; MEDICAL RESEARCH; MOLECULAR RECOGNITION; PARKINSON DISEASE; RNA TRANSLATION; SIDE EFFECT;

DRUG INDUSTRY; GENOMICS; MOLECULAR BIOLOGY; PHARMACOLOGY; RESEARCH SUPPORT;

EID: 0041328803     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02823-X     Document Type: Editorial

References (2)

1. Nutt J.G., et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 60:2003;69-73.
2. Frantz S., Smith A. New drug approvals for 2002. Nat. Rev. Drug Discov. 2:2003;95-96.